ArticleNeuro-oncology advances

MGMT function determines the differential response of ATR inhibitors with DNA-damaging agents in glioma stem cells for GBM therapy.

Vincent W S Leong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.